Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+97.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+97.6%/yr
vs -28.7%/yr prior
Acceleration
+126.3pp
Accelerating
Percentile
P82
Within normal range
vs 3Y Ago
7.7x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 22.07% |
| 2023 | 17.32% |
| 2022 | 0.86% |
| 2021 | 2.86% |
| 2020 | -24.10% |
| 2019 | -8.63% |
| 2018 | 53.43% |
| 2017 | 11.10% |
| 2016 | 56.02% |
| 2015 | -24.53% |